An epidemiological study was conducted by Crocus in 2016-2017 to obtain the data on the real prevalence of type 2 DM and pre-diabetes in adult population of Kazakhstan
Situation
The incidence and prevalence of type 2 diabetes mellitus (DM) has been increasing worldwide. Within Kazakhstan, there was a difference between the prevalence of DM estimated by International Diabetes Federation (6,2% of the adult population, 717500 adults respectively) and the reported prevalence of type 2 DM by the government of Kazakhstan (1,54% of the adult population, 272 484 adults respectively). This discrepancy was a serious concern for healthcare professionals, and greater understanding of the true prevalence of the metabolic condition was needed in order to provide more informed care to patients in Kazakhstan.
Solution
Crocus performed a cross-sectional epidemiological study sponsored by Sanofi, which enrolled over 14.948 subjects within Kazakhstan. Glycated haemoglobin A1c (HbA1c) samples were measured centrally by capillary electrophoresis. This cross-sectional study allowed Crocus to estimate a more accurate prevalence of type 2 DM in the adult population of Kazakhstan.
Demonstrated Capabilities
To determine the prevalence of type 2 DM in the adult population of Kazakhstan, Crocus provided the following services: Medical Writing, Data Management and Statistics.
Crocus’ strong data management skills revealed a significant difference between existing official data and revealed, thus demonstrating the serious underestimation of the problem.
Outcome
The results showed that the overall prevalence of Type 2 DM was 8,2% of the population in Kazakhstan- significantly higher that the existing official data.
